Oric Pharmaceuticals, Inc.
ORIC
Jodie situation report
Oric Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 12 directly disclosed connections are confirming.
- ORIC's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ORIC's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ORIC
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AVBPArriVent BioPharma, Inc.partnerMay 4, 2026 ▾
“We are also aware of several companies developing small molecule inhibitors against EGFR exon 20 insertion mutations and EGFR atypical mutations that are currently in clinical trials, including Cullinan Therapeutics in collaboration with Taiho Pharmaceutical,…”
BDTXFiling-linked namepartnerMay 4, 2026 ▾
“We are also aware of several companies developing small molecule inhibitors against EGFR exon 20 insertion mutations and EGFR atypical mutations that are currently in clinical trials, including Cullinan Therapeutics in collaboration with Taiho Pharmaceutical,…”
Depended on by
AVBPArriVent BioPharma, Inc.competitorMay 11, 2026 ▾
“We believe that our current and future competition for resources and eventually for customers comes from companies that are commercializing or developing candidates targeting EGFRm-positive NSCLC, including, but not limited to, 23 Table of Contents AstraZenec…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ORIC is currently a Follower in the organic co-movement group RNA Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ORIC; it is not active in the latest market snapshot.